Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples